MedPath

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluatio

Conditions
Type 2 diabetes and albuminuria
Registration Number
NL-OMON26322
Lead Sponsor
niversity Medical Center Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
52
Inclusion Criteria

•Type 2 diabetes

•eGFR > 45ml/min/1.73m2

Exclusion Criteria

•Pregnant women and women of child-bearing potential who are not using
reliable contraception

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Albuminuria reduction
Secondary Outcome Measures
NameTimeMethod
Glycocalyx thickness
© Copyright 2025. All Rights Reserved by MedPath